Citation Impact
Citing Papers
High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells
2005 StandoutScience
Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers
2005
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy
2001 Science
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
2018
A double‐blind, placebo‐controlled phase II study of the efficacy and safety of 2,2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
Mesenchymal stem cells avoid allogeneic rejection
2005
A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis
2017
Statistical Model to Analyze Quantitative Proteomics Data Obtained by 18O/16O Labeling and Linear Ion Trap Mass Spectrometry
2009
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
Thiazolidinediones
2004 Standout
The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro
2004
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
2008
Pathogenesis and Treatment of Sickle Cell Disease
1997
Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors
2010
Hepatocyte growth factor promotes lymphatic vessel formation and function
2005
The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism
2008
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
The β-Thalassemias
1999 Standout
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
2004
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
2000
Wound repair and regeneration
2008 StandoutNature
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
2002
Hypoxia and Inflammation
2011 Standout
Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators
2000
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Endogenous angiogenesis inhibitors
2004
Sickle-cell disease
1997
Lung Stem Cell Differentiation in Mice Directed by Endothelial Cells via a BMP4-NFATc1-Thrombospondin-1 Axis
2014
NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS
1995
Lymphangiogenesis in development and human disease
2005 StandoutNature
Integrins in angiogenesis: multitalented molecules in a balancing act
2003
Metazoan MicroRNAs
2018 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
2008
A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger
2008
PPARγ in the endothelium regulates metabolic responses to high-fat diet in mice
2008
Sickle-cell disease
2010 Standout
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
2003
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Met, metastasis, motility and more
2003 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Cellular and Molecular Mechanisms of Vascular Lumen Formation
2009
Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation
2003
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
What We Talk About When We Talk About Fat
2014 Standout
Rho and Rac Take Center Stage
2004 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Long-term Pharmacological Activation of PPARγDoes not Prevent Left Ventricular Remodeling in Dogs with Advanced Heart Failure
2007
5 Thalassaemia: clinical management
1998
Medical significance of peroxisome proliferator-activated receptors
1999
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
2016 StandoutNobel
Disorders of Iron Metabolism
1999 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Tumor Angiogenesis
2008 Standout
Pharmacologic Modulation of Fetal Hemoglobin
2001
Roles of PPARs in health and disease
2000 StandoutNature
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Angiogenesis Research: Guidelines for Translation to Clinical Application
2001
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Biology of the p21-Activated Kinases
2003
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
2016
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
2003
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
The peroxisome proliferator-activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function
1999
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
HIF‐dependent induction of adenosine A2B receptor in hypoxia
2006
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
2003
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
2009
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Induction of human γ globin gene expression by histone deacetylase inhibitors
2003
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
2011 Standout
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
2002
Angiogenesis in Endocrine Tumors
2003
Peroxisome Proliferator-Activated Receptor γ Target Gene Encoding a Novel Angiopoietin-Related Protein Associated with Adipose Differentiation
2000
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Differential effects of exercise on insulin-signaling gene expression in human skeletal muscle
2001
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
2011
Works of Suya Yang being referenced
Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo
2001
Stanniocalcin 1 Is an Autocrine Modulator of Endothelial Angiogenic Responses to Hepatocyte Growth Factor
2003
Functional Roles for PECAM-1 (CD31) and VE-Cadherin (CD144. in Tube Assembly and Lumen Formation in Three-Dimensional Collagen Gels
1999
Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo
1999
Branching Out: A Molecular Fingerprint of Endothelial Differentiation into Tube‐Like Structures Generated by Affymetrix Oligonucleotide Arrays
2003
Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies
1995
A Dominant-Negative p65 PAK Peptide Inhibits Angiogenesis
2002
Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells
2004
Sequences in the A γ–δ intergenic region are not required for stage-specific regulation of the human β-globin gene locus
2003
Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb β s -globin yeast artificial chromosome: A mouse model of sickle cell anemia
1998
Vascular Endothelial Growth Factor–Induced Genes in Human Umbilical Vein Endothelial Cells
2002